BioSmart Co.,Ltd.
Financials
Valuation Metrics
BioSmart Co.,Ltd.'s Market Cap is ₩593B. At end of 2025 it was ₩986B. Ranked #1586 of 2,410 in KR market (top 66%), #931 of 1,631 on KOSDAQ (top 57%), #143 of 243 in Technology Hardware & Equipment (top 59%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 59.27B KRW | KR#1,586/2,410 Sec#143/243 |
| Revenue | 562.68B KRW | KR#580/2,410 Sec#33/243 |
| Net Income | 18.26B KRW | KR#737/2,410 Sec#58/243 |
| Total Assets | 345.35B KRW | KR#956/2,410 Sec#67/243 |
| Net Assets | 197.41B KRW | KR#954/2,410 Sec#71/243 |
| Employees | 163 | KR#1,250/2,410 Sec#92/243 |
| Value | ||
| P/E | 3.25x | KR#207/2,410 Sec#28/243 |
| P/B | 0.30x | KR#405/2,410 Sec#26/243 |
| PEG | 0.00x | KR#72/2,410 Sec#11/243 |
| P/S | 0.11x | KR#173/2,410 Sec#14/243 |
| EV/EBITDA | 3.99x | KR#183/2,410 Sec#20/243 |
| FCF Yield | -15.48% | KR—/2,410 Sec—/243 |
| Profitability | ||
| ROE | 9.25% | KR#676/2,410 Sec#79/243 |
| ROA | 5.29% | KR#703/2,410 Sec#90/243 |
| Op. Margin | 4.97% | KR#964/2,410 Sec#88/243 |
| Revenue Growth | -16.91% | KR#2,075/2,410 Sec#207/243 |
| Earnings Growth | 663.81% | KR#90/2,410 Sec#11/243 |
| Financial Health | ||
| Debt Ratio | 74.94% | KR#1,276/2,410 Sec#138/243 |
| Total Debt | 90.09B KRW | KR#764/2,410 Sec#54/243 |
| FCF | -9.17B KRW | KR#1,675/2,410 Sec#164/243 |
| Cash | 37.87B KRW | KR#882/2,410 Sec#76/243 |
| Current Ratio | 1.44x | KR#1,250/2,410 Sec#140/243 |
| Net Debt/EBITDA | 1.87x | KR#823/2,410 Sec#89/243 |
| Dividend | ||
| Div. Growth | 290.33% | KR#32/2,410 Sec#5/243 |
| Performance | ||
| 1Y Return | -14.88% | KR#969/2,410 Sec#114/243 |
| 1M Return | -18.72% | KR#1,721/2,410 Sec#164/243 |
| From 52W High | -66.16% | KR#1,923/2,410 Sec#180/243 |
| 1Y MDD | -62.80% | KR#1,609/2,410 Sec#135/243 |
| Trading | ||
| Volume | 39,470 shares | KR#565/2,410 Sec#66/243 |
| Trading Value | 92.4M KRW | KR#1,032/2,410 Sec#103/243 |
| Foreign Own. | 7.18% | KR#620/2,410 Sec#65/243 |
| Per Share | ||
| EPS | 723 KRW | KR#855/2,410 Sec#87/243 |
| BPS | 7,811 KRW | KR#1,150/2,410 Sec#109/243 |
Company Info
Listed on KOSDAQ in 2000, the company is a mid-sized enterprise with five consolidated subsidiaries. It operates businesses in smart cards, pharmaceuticals, alcohol payment, book publishing, diagnostic kits, and heavy electric equipment manufacturing and repair, seeking increased synergy by combining diverse industries. The smart card division leads the domestic IC card and smart card market and has obtained global card company approval. The pharmaceuticals division boasts a portfolio of approximately 300 types of professional and general pharmaceuticals. BIOSMART is headquartered in Seongdong-gu, Seoul.